Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,865
archived clinical trials in
Multiple Sclerosis

Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Asheville, NC
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Akron, OH
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Akron, OH
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Franklin, TN
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Franklin, TN
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Vienna, VA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Vienna, VA
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Seattle, WA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Tucson, AZ
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Berkeley, CA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Berkeley, CA
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
San Diego, CA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Port Charlotte, FL
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Sarasota, FL
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
St. Petersburg, FL
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Tampa, FL
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Lenexa, KA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Lenexa, KA
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Detroit, MI
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Toms River, NJ
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Toms River, NJ
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Patchogue, NY
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Patchogue, NY
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Plainview, NY
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Plainview, NY
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Nashville, TN
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
San Antonio, TX
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated:  12/28/2015
XenoPort Clinical Site
mi
from
Tacoma, WA
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Status: Enrolling
Updated: 12/28/2015
XenoPort Clinical Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
HOPE Research Institute
mi
from
Phoenix, AZ
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
HOPE Research Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Neurological Associates
mi
from
Fayetteville, AR
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Neurological Associates
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Alta Bates Summit Medical Center - Research and Education Institute
mi
from
Berkeley, CA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Alta Bates Summit Medical Center - Research and Education Institute
mi
from
Berkeley, CA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
USC, Keck School of Medicine Health Care Consultation Center
mi
from
Los Angeles, CA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
USC, Keck School of Medicine Health Care Consultation Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
UC Davis
mi
from
Sacramento, CA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
UC Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Yale University MS Center
mi
from
New Haven, CT
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Yale University MS Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Shepherd Center
mi
from
Atlanta, GA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Shepherd Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Consultants in Neurology, Ltd.
mi
from
Northbrook, IL
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Consultants in Neurology, Ltd.
mi
from
Northbrook, IL
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Indiana University MS Center
mi
from
Indianapolis, IN
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Indiana University MS Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Associates in Neurology PSC
mi
from
Lexington, KY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Associates in Neurology PSC
mi
from
Lexington, KY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Maryland Center for MS
mi
from
Baltimore, MD
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Maryland Center for MS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Lahey Clinic
mi
from
Lexington, MA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Lahey Clinic
mi
from
Lexington, MA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
The Schapiro Center for MS
mi
from
Golden Valley, MN
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
The Schapiro Center for MS
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Advanced Neurology Specialists
mi
from
Great Falls, MT
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Advanced Neurology Specialists
mi
from
Great Falls, MT
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
UMDNJ
mi
from
Newark, NJ
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
UMDNJ
mi
from
Newark, NJ
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Gimbel MS Center at Holy Name Hospital
mi
from
Teaneck, NJ
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Gimbel MS Center at Holy Name Hospital
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Jacobs Neurological Institute: Buffalo General Hospital
mi
from
Buffalo, NY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Jacobs Neurological Institute: Buffalo General Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Corinne Goldsmith Dickinson Center for MS
mi
from
New York, NY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Corinne Goldsmith Dickinson Center for MS
mi
from
New York, NY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Columbia University Multiple Sclerosis Clinical Care Center
mi
from
New York, NY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Columbia University Multiple Sclerosis Clinical Care Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
University of Rochester
mi
from
Rochester, NY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
SUNY Stony Brook
mi
from
Stony Brook, NY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
SUNY Stony Brook
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
CMC - Neuroscience & Spine Institute, Division of Neurology
mi
from
Charlotte, NC
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
CMC - Neuroscience & Spine Institute, Division of Neurology
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Raleigh Neurology Associates
mi
from
Raleigh, NC
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Wake Forest University, Dept of Neurology, M.S. Research
mi
from
Winston-Salem, NC
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Wake Forest University, Dept of Neurology, M.S. Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
The Center for Neurological Services
mi
from
Bismarck, ND
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
The Center for Neurological Services
mi
from
Bismarck, ND
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Ohio State University MS Center
mi
from
Columbus, OH
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Ohio State University MS Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Oregon Health & Science University, MS Center of Oregon, UHS-42
mi
from
Portland, OR
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Oregon Health & Science University, MS Center of Oregon, UHS-42
mi
from
Portland, OR
Click here to add this to my saved trials